These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1740519)

  • 1. Increased serum concentrations of tumour necrosis factor in beta thalassaemia: effect of bone marrow transplantation.
    Meliconi R; Uguccioni M; Lalli E; Nesci S; Delfini C; Paradisi O; Lucarelli G; Gasbarrini G; Facchini A
    J Clin Pathol; 1992 Jan; 45(1):61-5. PubMed ID: 1740519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated inflammatory cytokine levels in bone marrow graft rejection.
    Nagler A; Or R; Nisman B; Kalickman I; Slavin S; Barak V
    Transplantation; 1995 Nov; 60(9):943-8. PubMed ID: 7491698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated interleukin-8 serum concentrations in beta-thalassemia and graft-versus-host disease.
    Uguccioni M; Meliconi R; Nesci S; Lucarelli G; Ceska M; Gasbarrini G; Facchini A
    Blood; 1993 May; 81(9):2252-6. PubMed ID: 8481507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.
    Uguccioni M; Meliconi R; Lalli E; Nesci S; Delfini C; Lucarelli G; Gasbarrini G; Facchini A
    J Clin Pathol; 1992 Apr; 45(4):348-51. PubMed ID: 1577974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
    Toren A; Barak V; Novick D; Nagler A
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Hill GR; Cooke KR; Brinson YS; Bungard D; Ferrara JL
    Transplantation; 1999 Jun; 67(11):1478-80. PubMed ID: 10385089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.
    Hill GR; Teshima T; Gerbitz A; Pan L; Cooke KR; Brinson YS; Crawford JM; Ferrara JL
    J Clin Invest; 1999 Aug; 104(4):459-67. PubMed ID: 10449438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum levels of circulating intercellular adhesion molecule 1 predict the risk of graft rejection after bone marrow transplantation for thalassemia.
    Centis F; Delfini C; Annibali M; Galimberti M; Agostinelli F; Nicolini G; Lucarelli G
    Bone Marrow Transplant; 1997 Jul; 20(2):125-8. PubMed ID: 9244415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
    Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
    Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of transplant-related complications in patients with chronic release of tumor necrosis factor-alpha before admission to bone marrow transplantation: a clinical correlate of cytokine desensitization?
    Holler E; Hintermeier-Knabe R; Kolb HJ; Kempeni J; Möller A; Liesenfeld S; Daum L; Wilmanns W
    Pathobiology; 1991; 59(3):171-5. PubMed ID: 1883512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Outcomes in Young Class 3 Patients With Thalassemia Undergoing HLA-Identical Sibling Bone Marrow Transplantation.
    Gaziev J; Isgrò A; Sodani P; Marziali M; Paciaroni K; Gallucci C; De Angelis G; Andreani M; Testi M; Alfieri C; Ribersani M; Galluccio T; Battarra MR; Morrone A; Lucarelli G
    Transplantation; 2016 Apr; 100(4):925-32. PubMed ID: 26457600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor-Alpha Production in Mice after Bone Marrow Transplantation.
    Liu J; Guo YM; Onai N; Ohyagi H; Hirokawa M; Takahashi N; Tagawa H; Ubukawa K; Kobayashi I; Tezuka H; Minamiya Y; Ohteki T; Sawada K
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):627-636. PubMed ID: 26740374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation.
    Nagler A; Bishara A; Brautbar C; Barak V
    Cytokines Cell Mol Ther; 1998 Sep; 4(3):161-7. PubMed ID: 9825841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
    Takabayashi M; Kanamori H; Takasaki H; Yamaji S; Koharazawa H; Taguchi J; Tomita N; Fujimaki K; Fujisawa S; Maruta A; Ishigatsubo Y
    Exp Hematol; 2005 Feb; 33(2):251-7. PubMed ID: 15676220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.